Evaxion A (EVAX) Receivables - Net (2019 - 2025)
Evaxion A's (EVAX) quarterly Receivables - Net came in at $424000.0 in Q2 2025, up 8.16% YoY from $392000.0 in Q2 2024, and up 8.16% on a QoQ basis from $392000.0 in Q2 2024.
Evaxion A (EVAX) Receivables - Net (2019 - 2025) Analysis & Trends
Evaxion A (EVAX) has 7 years of Receivables - Net data on file, last reported at $424000.0 in Q2 2025.
- Quarterly Receivables - Net rose 8.16% year-over-year to $424000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $424000.0 (up 8.16% YoY) and the FY2023 annual result came in at $2.0 million, down 30.06% from the prior year.
- Receivables - Net climbed to $424000.0 in Q2 2025, from $392000.0 in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $2.8 million in Q4 2022 to a low of $245000.0 in Q1 2022.
- A 5-year average of $830857.1 and a median of $424000.0 in 2025 frame the typical range for Receivables - Net.
- Annual changes were most pronounced in 2021 — Receivables - Net decreased 26.72% — and 2022, when it surged 145.25%.
- Tracing EVAX's Receivables - Net over 5 years: stood at $1.1 million in 2021, then surged by 145.25% to $2.8 million in 2022, then plunged by 84.77% to $425000.0 in 2023, then declined by 7.76% to $392000.0 in 2024, then advanced by 8.16% to $424000.0 in 2025.
- The last three Receivables - Net figures came in at $424000.0 (Q2 2025), $392000.0 (Q2 2024), and $425000.0 (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.18 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.98 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.37 Bn | 59.19 Bn | 1.37 Bn |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.75 Bn | 9.35 Bn | 668.28 Mn |
| 8 | Insmed | 27.24 Bn | 26.08 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.03 Bn | 26.20 Bn | - |
| 10 | Evaxion A | 27.61 Mn | 27.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 424,000.00 |
| Jun 30, 2025 | 424,000.00 |
| Jun 30, 2024 | 392,000.00 |
| Jun 30, 2024 | 392,000.00 |
| Jun 30, 2023 | 425,000.00 |
| Jun 30, 2023 | 425,000.00 |
| Dec 31, 2022 | 2.79 Mn |
| Dec 31, 2022 | 2.79 Mn |
| Jun 30, 2022 | 401,000.00 |
| Jun 30, 2022 | 401,000.00 |
| Mar 31, 2022 | 245,000.00 |
| Mar 31, 2022 | 245,000.00 |
| Dec 31, 2021 | 1.14 Mn |
| Dec 31, 2021 | 1.14 Mn |
| Dec 31, 2020 | 1.55 Mn |
| Dec 31, 2020 | 1.55 Mn |
| Dec 31, 2019 | 575,000.00 |
| Dec 31, 2019 | 575,000.00 |